Boothbay Fund Management’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-14,491
| Closed | -$260K | – | 1542 |
|
|
2024
Q4 | $260K | Sell |
14,491
-27
| -0.2% | -$484 | 0.01% | 966 |
|
|
2024
Q3 | $234K | Sell |
14,518
-54,022
| -79% | -$871K | 0.01% | 1165 |
|
|
2024
Q2 | $1.85M | Buy |
+68,540
| New | +$1.85M | 0.04% | 445 |
|
|
2022
Q3 | – | Sell |
-893
| Closed | -$35K | – | 2247 |
|
|
2022
Q2 | $35K | Buy |
+893
| New | +$35K | ﹤0.01% | 1854 |
|
|
2022
Q1 | – | Sell |
-401
| Closed | -$39K | – | 2130 |
|
|
2021
Q4 | $39K | Buy |
+401
| New | +$39K | ﹤0.01% | 1621 |
|
|
2020
Q1 | – | Sell |
-5,528
| Closed | -$395K | – | 933 |
|
|
2019
Q4 | $395K | Buy |
+5,528
| New | +$395K | 0.03% | 458 |
|
|
2018
Q2 | – | Sell |
-1,017
| Closed | -$311K | – | 762 |
|
|
2018
Q1 | $311K | Buy |
+1,017
| New | +$311K | 0.04% | 360 |
|